Daniel Offen News Today

Israeli-Canadian NurExone Biologic is developing groundbreaking exosome technology for treatment of spinal cord injuries and additional indications

Calgary, Alberta--(Newsfile Corp. - June 15, 2022) - NurExone Biologic Inc. (formerly, EnerSpar Corp.) (TSXV: NRX) (the "Company") is pleased to announce that it has completed its previously announced

Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale of branded CBD-integrated pharmaceutical and topical treatment products

Bird flu outbreak in Israel, Lebanon results in culling over 500,000 birds; 5,000 wild cranes found dead at the Hula Lake nature reserve.

Scientists say their work may cause a pivot in research, as it suggests THC is the more promising cannabinoid than CBD

We saw that cannabis oil has a favorable effect on compulsive and anxious behaviors in model animals - Click the link for more details.

Researchers at Tel Aviv University have successfully treated autism in animal models with medical cannabis oil. The researchers found that this treatment improves both behavioural and biochemical parameters of autism. The results of the surprising study were published in Translational Psychology published by Nature. The research team was led by PhD student Shani Poleg and Prof. Daniel…

Scientists from Tel Aviv University demonstrated the positive effect of cannabis oils in animal models in a laboratory.

Researchers at Tel Aviv University, led by Ph.D. student Shani Poleg and Prof. Daniel Offen of the Sackler Faculty of Medicine, Felsenstein Medical